CompletedNot Applicable

Application and Evaluation of Vision-LSTM Modeling in Diagnostic Ultrasound Imaging of TI-RADS Category 4b Thyroid Nodules

China401 participantsStarted 2022-01-01

Plain-language summary

The aim of this study was to evaluate the performance of artificial intelligence (AI) technology in the diagnosis of thyroid nodules, specifically in the field of ultrasound image analysis. It focuses on the accuracy and clinical feasibility of the AI system based on the Vision-LSTM model in the diagnosis of TI-RADS category 4b thyroid nodules.

Who can participate

Age range20 Years – 78 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:(1) Patients with thyroid nodules visible on ultrasound who underwent biopsy and/or surgical resection. (2) Diagnosed as TI-RADS category 4b on the basis of preoperative ultrasound images by two sonographers with more than 5 years of experience in thyroid ultrasound diagnosis. (3) All nodules underwent puncture biopsy or surgery to obtain pathologic results. \- Exclusion Criteria:(1)The quality of the patient's ultrasound images was poor. (2) The patient has incomplete clinical and imaging data. (3) The patient has had thyroid surgery or other treatment. \-

What they're measuring

Accuracy of diagnostic models

Timeframe: Immediately evaluated after the diagnostic model was built

Trial details

NCT IDNCT07496684

SponsorMa Zhe

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-30

View on ClinicalTrials.gov More Thyroid Cancer trials